Title:Cardiac Multimodality Imaging in Hypertrophic Cardiomyopathy: What
to Look for and When to Image
Volume: 19
Issue: 5
Author(s): Perry Wengrofsky, Yonatan Akivis and Inna Bukharovich*
Affiliation:
- Division of Cardiology,
Department of Medicine, NYC Health and & Hospitals, Kings County, Brooklyn, NY 11203, USA
Keywords:
Hypertrophic cardiomyopathy, multimodality imaging, echocardiography, cardiac magnetic resonance imaging, cardiac computed tomography, cardiac death risk.
Abstract: Hypertrophic cardiomyopathy (HCM), now recognized as a common cardiomyopathy of
complex genomics and pathophysiology, is defined by the presence of left ventricular hypertrophy
of various morphologies and severity, significant hemodynamic consequences, and diverse phenotypic,
both structural and clinical, profiles. Advancements in cardiac multimodality imaging, including
echocardiography, cardiac magnetic resonance imaging, and cardiac computed tomography,
with and without angiography have greatly improved the diagnosis of HCM, and enable precise
measurements of cardiac mass, volume, wall thickness, function, and physiology. Multimodality
imaging provides comprehensive and complementary information and hasemerged as the bedrock
for the diagnosis, clinical assessment, serial monitoring, and sudden cardiac death risk stratification
of patients with HCM. This review highlights the role of cardiac multimodality imaging in
the modern diagnosis and management of HCM.
